Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/82058
DC Field | Value | Language |
---|---|---|
dc.contributor | Department of Applied Biology and Chemical Technology | - |
dc.creator | Lee, MY | en_US |
dc.creator | Han, Y | en_US |
dc.creator | Choi, CLZhang, Z | en_US |
dc.creator | Cui, W | en_US |
dc.date.accessioned | 2020-05-05T05:58:29Z | - |
dc.date.available | 2020-05-05T05:58:29Z | - |
dc.identifier.uri | http://hdl.handle.net/10397/82058 | - |
dc.language.iso | en | en_US |
dc.rights | Assignee: University of Macau | en_US |
dc.rights | Assignee: The Hong Kong Polytechnic University | en_US |
dc.title | Uses of indole-ketones or indolidones as neuro-protective drugs | en_US |
dc.type | Patent | en_US |
dc.description.otherinformation | US9486440; US9486440 B2; US9486440B2; US9,486,440; US9,486440 B2; 9486440; 15/836,54014/354,137 | en_US |
dcterms.abstract | The present invention provides a method of using indole-ketone or indolidone such as SU4312, SU5416, SU11248 (Sunitinib), or indirubin-3-oxime to treat a neurodegenerative disease or disorder such as Parkinson's disease which is associated with excessive neuronal Nitric Oxide Synthase (nNOS) activity. | - |
dcterms.bibliographicCitation | US Patent US9,486440 B2. Washington, DC: US Patent and Trademark Office, 2016. | en_US |
dcterms.issued | 2016-11-08 | - |
dc.description.country | US | - |
dc.description.validate | 202006 bcrc | - |
dc.description.oa | Version of Record | en_US |
Appears in Collections: | Patent |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
us9486440b2.pdf | 4.98 MB | Adobe PDF | View/Open |
Page views
58
Last Week
1
1
Last month
Citations as of Mar 24, 2024
Downloads
25
Citations as of Mar 24, 2024
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.